Psilocybin clinical trial confirms safety of group psychedelic sessions
A new study published in the The Journal of Psychopharmacology found no detrimental effects from simultaneous administration of the drug.
Science & academia
NASA fully deploys world’s most powerful space telescope
NASA partnered with the European and Canadian space agencies to build and launch the new 7-ton telescope, with thousands of people from 29 countries working on it since the 1990s.
Researchers disable long-targeted gene behind spread of major cancers
Princeton University researchers have discovered what they call a “silver bullet” in the form of a compound that can disable the gene that allows most major cancers to metastasize in mice and human tissue.
Largest-ever psilocybin trial finds the psychedelic is effective in treating serious depression
Overall, 29.1% of patients in the highest-dose group were in remission three weeks after treatment, compared to 7.6% of those in the control group.
China’s first clinic for transgender children and adolescents set up in Shanghai
Experts expect that the clinic will serve as a bridge between transgender children, parents, doctors and the various circles of society.
HPV vaccine cutting cervical cancer by 87% in the U.K., shows new study
Cancer Research UK described the findings as “historic”, and said it showed the vaccine was saving lives.
MIT-designed project achieves major advance toward fusion energy
A new superconducting magnet breaks magnetic field strength records, paving the way for practical, commercial, carbon-free power.
Johns Hopkins Medicine receives first federal grant for psychedelic treatment research in 50 years
Combined with preparation and structured support, psilocybin has shown promise for treating a range of addictions and mental health disorders.
Psychedelics linked to lower heart disease and diabetes risk in new study
“The findings suggest that lifetime classic psychedelic use is associated with lower odds of having had heart disease or diabetes in the past year,” lead study author and Oxford sociologist Otto Simonsson.
New cancer treatment destroys tumors in terminally ill head and neck cancer patients
In a landmark trial, a cocktail of immunotherapy medications harnessed patients’ immune systems to kill their own cancer cells and prompted “a positive trend in survival.”